R. Steinkampf

发表

Lack of effect of corticosteroids and tamoxifen on suramin protein binding and in vitro activity.

C. Kowal, L. Paradiso, D. Driscoll, 1996, European journal of cancer.

2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.

D. Boschelli, A. Doherty, H. D. Showalter, 1998, Journal of medicinal chemistry.

Structure-activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Wee1.

W. Denny, G. Rewcastle, A. Kraker, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.

D. Boschelli, A. Doherty, H. D. Showalter, 1998, Journal of medicinal chemistry.

3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.

W. Denny, H. D. Showalter, J. M. Hamby, 2000, Journal of medicinal chemistry.

Evaluation of galactosyltransferase isoenzyme II in a human colon carcinoma-derived cell line, HCT-8.

J. Tunac, W. Klohs, R. Steinkampf, 1986, European journal of cancer & clinical oncology.

Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.

R. Jackson, W. Klohs, R. Steinkampf, 1986, Cancer research.

Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy

T. Dougherty, B. Henderson, M. Schroeder, 2004, Investigational New Drugs.

Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells.

W. Klohs, R. Steinkampf, 1988, Cancer research.

The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.

W. Klohs, R. Steinkampf, 1988, Molecular pharmacology.

Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301U.

D. W. Fry, W. Klohs, J. Besserer, 1986, Cancer letters.

Role of a small molecular weight phosphoprotein in the mechanism of action of CI‐994 (N‐acetyldinaline)

A. Kraker, K. Hook, S. Rummel, 1995, International journal of cancer.

2-Substituted Aminopyrido[2,3- d ]pyrimidin-7(8 H )-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity

D. Boschelli, A. Doherty, H. D. Showalter, 1998 .

Collagen-production inhibitors evaluated as antitumor agents.

M. Wicha, W. Leopold, J. Tunac, 1985, Journal of the National Cancer Institute.